住院低血糖患者的死亡率:胰岛素相关与非胰岛素相关低血糖
该研究基于2011年1月至2013年12月内科病房住院的33675例成人患者的前瞻性历史数据,分析胰岛素相关与非胰岛素相关低血糖与全因死亡率的关联。结果显示,无论是否使用胰岛素,低血糖均与短期和长期死亡率升高相关。
要点
- 低血糖定义为血糖<70 mg/dl(3.9 mmol/l),并分为中度(40-70 mg/dl,2.2-3.9 mmol/l)和重度(<40 mg/dl,2.2 mmol/l)。
- 随访结束时总死亡率为31.9%,非胰岛素治疗对照组为28.0%,胰岛素治疗对照组为42.9%。
- 多因素分析后,与非胰岛素治疗对照组相比,胰岛素相关重度低血糖的风险比为3.6,非胰岛素相关重度低血糖的风险比为3.2。
核心结论
- 住院患者中,胰岛素相关或自发性低血糖均与短期和长期死亡率升高相关。
研究设计与样本
- 研究采用2011年1月至2013年12月期间因任何原因入住内科病房的18岁及以上患者的历史前瞻性数据。
- 低血糖定义为血糖<70 mg/dl(3.9 mmol/l),包括中度(40-70 mg/dl,2.2-3.9 mmol/l)和重度(<40 mg/dl,2.2 mmol/l)。
- 住院期间使用胰岛素定义为胰岛素相关低血糖,患者分为6组:非胰岛素治疗对照组(NITC)、胰岛素治疗对照组(ITC)、胰岛素相关低血糖(IH)、胰岛素相关重度低血糖(ISH)、非胰岛素相关低血糖(NIH)和非胰岛素相关重度低血糖(NISH)。
- 队列共纳入33675例患者,其中中度低血糖2605例(IH 1011例,NIH 1594例),重度低血糖342例(ISH 201例,NISH 141例)。
主要发现
- 随访结束时总死亡率为31.9%,其中NITC组28.0%,ITC组42.9%,NIH组50.7%,IH组55.3%,NISH组70.9%,ISH组69.1%。
- 与NITC组相比,未调整的风险比(95%置信区间)分别为:ITC 1.7(1.6-1.8),NIH 2.2(2.0-2.4),IH 2.5(2.2-2.7),NISH 4.2(3.5-5.2),ISH 3.8(3.2-4.5),P<0.001。
- 多因素分析后,相应的风险比分别为1.8、2.1、2.4、3.2和3.6(P<0.001)。
- 入院原因不影响上述关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Hypoglycemia is common among hospitalized patients with and without diabetes mellitus. OBJECTIVE: Investigate the association between spontaneous or insulin-related hypoglycemia and mortality in hospitalized patients. DESIGN: Hypoglycemia was defined as blood glucose <70 mg/dl (3.9 mmol/l), including moderate (40 to 70 mg/dl, 2.2 to 3.9 mmol/l) and severe hypoglycemia (<40 mg/dl, 2.2 mmol/l). Use of insulin during hospitalization defined insulin-related hypoglycemia, thus patients were classified into 6 groups: non-insulin treated (NITC) and insulin-treated controls (ITC), insulin-related hypoglycemia (IH) or severe hypoglycemia (ISH), and non insulin-related hypoglycemia (NIH) and severe hypoglycemia (NISH). SETTING AND PATIENTS: Historical prospectively data of patients ≥ 18 years of age, hospitalized in medical wards for any cause between January 2011 and December 2013. MAIN OUTCOME MEASURE: All-cause mortality at the end of follow-up. RESULTS: The cohort included 33,675 patients, including 2605 with moderate hypoglycemia (IH, 1011; NIH, 1594) and 342 with severe hypoglycemia (ISH, 201; NISH,141). Overall end-of-follow-up mortality was 31.9% (NITC, 28.0%; ITC, 42.9%; NIH, 50.7%; IH, 55.3%; NISH, 70.9%; ISH, 69.1%). Compared with NITC, unadjusted hazard ratios (95% confidence intervals) for mortality were as follows: ITC, 1.7 (1.6 to 1.8), NIH, 2.2 (2.0 to 2.4), IH, 2.5 (2.2 to 2.7), NISH, 4.2 (3.5 to 5.2), and ISH, 3.8 (3.2 to 4.5); with P < 0.001. Following multivariate analysis, respective hazard ratios were 1.8, 2.1, 2.4, 3.2, and 3.6 (P < 0.001). Cause of admission did not affect the association. CONCLUSIONS: In hospitalized patients, hypoglycemia, either with insulin use or spontaneous, is associated with increased short- and long-term mortality.
引用
- Akirov A, Grossman A, Shochat T, et al. Mortality Among Hospitalized Patients With Hypoglycemia: Insulin Related and Noninsulin Related. J Clin Endocrinol Metab. 2017. PMID: 27854553. doi:10.1210/jc.2016-2653
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。